TruScreen provides an accurate, real-time screening solution. Our primary screening solution is ideal for communities that cannot access conventional, laboratory dependant, screening methods. It is affordable and easy to learn.
Our purpose is to ensure that all women of screening age, no matter who or where they are, have access to quality screening.
What is TruScreen?Investing in cervical cancer screening and treatment is highly impactful for several reasons:
Established in 2013, TruScreen has been working towards its vision of A World Without Cervical Cancer.
Our PeopleOur market potential is huge with over a billion women eligible for screening in our key markets.
TruScreen's MarketsWHO estimates that in 2020, there was 600,000+ new cases of cervical cancer worldwide.
Learn more about Cervical CancerThe TruScreen device has been clinically validated on over 40,000 women in multiple settings.*
MORE DATA